ChainCatcher 消息，Cathie Wood 在 X 平台发文表示，根据 ARKInvest 的研究，AI 最深远的应用领域将是医疗保健。放松管制正在加速医疗保健领域的这一变革。评估药物疗效的科学已取得巨大进步，研发项目通过作用机制、生物标志物效应和中间终点等多维度收集证据，这些从机制数据到真实世界证据的验证性证据可替代第二项关键试验。
历史上在罕见病和肿瘤领域已有较大监管灵活性，预计此次从两项降至一项的改变将在心血管和呼吸等常见疾病领域产生最大影响，每个项目有望节省高达 3.5 亿美元成本并缩短数年研发周期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.